106 related articles for article (PubMed ID: 2016687)
1. Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice.
Morrey JD; Okleberry KM; Sidwell RW
J Acquir Immune Defic Syndr (1988); 1991; 4(5):506-12. PubMed ID: 2016687
[TBL] [Abstract][Full Text] [Related]
2. Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.
Morrey JD; Warren RP; Okleberry KM; Burger RA; Johnston MI; Sidwell RW
J Acquir Immune Defic Syndr (1988); 1990; 3(5):500-10. PubMed ID: 2157836
[TBL] [Abstract][Full Text] [Related]
3. Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T).
Sidwell RW; Hitchcock M; Okleberry KM; Burger RA; Warren RP; Morrey JD
Antiviral Res; 1992 Oct; 19(4):313-24. PubMed ID: 1334395
[TBL] [Abstract][Full Text] [Related]
4. Requirement for CD4(+) T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice.
Super HJ; Brooks D; Hasenkrug K; Chesebro B
J Virol; 1998 Nov; 72(11):9400-3. PubMed ID: 9765497
[TBL] [Abstract][Full Text] [Related]
5. Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection.
Morrey JD; Warren RP; Okleberry KM; Burger RA; Chirigos MA; Sidwell RW
Antiviral Res; 1991 Jan; 15(1):51-65. PubMed ID: 2036000
[TBL] [Abstract][Full Text] [Related]
6. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production.
Doig D; Chesebro B
J Exp Med; 1979 Jul; 150(1):10-9. PubMed ID: 286744
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulator effects on the Friend virus infection in genetically defined mice.
Sidwell RW; Morrey JD; Okleberry KM; Burger RA; Warren RP
Ann N Y Acad Sci; 1993 Jun; 685():432-46. PubMed ID: 8363251
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of continuous zidovudine infusion at early stages of retroviral infection in mice.
Sinet M; Harcouet L; Desforges B; Colin JN; Farinotti R; Pocidalo JJ
J Acquir Immune Defic Syndr (1988); 1992; 5(6):577-82. PubMed ID: 1316960
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats.
Hayes KA; Lafrado LJ; Erickson JG; Marr JM; Mathes LE
J Acquir Immune Defic Syndr (1988); 1993 Feb; 6(2):127-34. PubMed ID: 8381867
[TBL] [Abstract][Full Text] [Related]
10. Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression.
Morrison RP; Nishio J; Chesebro B
J Exp Med; 1986 Feb; 163(2):301-14. PubMed ID: 3456010
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
Kitagawa M; Kamisaku H; Aizawa S; Sado T
Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice.
Sinet M; Desforges B; Launay O; Colin JN; Pocidalo JJ
Antiviral Res; 1991 Sep; 16(2):163-71. PubMed ID: 1799277
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of FK-565 alone and in combination with zidovudine on retroviral infection by Friend leukemia virus in mice.
Yokota Y; Wakai Y; Watanabe Y; Mine Y
J Antibiot (Tokyo); 1988 Oct; 41(10):1479-87. PubMed ID: 3192497
[TBL] [Abstract][Full Text] [Related]
14. Genetic resistance to Friend leukemia virus in mice: masking of Fv-2 phenotype by an epistatic gene, Fv-4.
Odaka T; Ikeda H
Jpn J Exp Med; 1977 Dec; 47(6):515-21. PubMed ID: 609115
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effect of D-aspartic acid beta-hydroxamate (DAH) on Friend virus-infected erythropoietic progenitor cells.
Tournaire R; Arnaud S; Hamedi-Sangsari F; Malley S; Grange J; Blanchet JP; Doré JF; Vila J
Leukemia; 1994 Oct; 8(10):1703-7. PubMed ID: 7934166
[TBL] [Abstract][Full Text] [Related]
16. Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex.
Lu L; Hangoc G; Oliff A; Chen LT; Shen RN; Broxmeyer HE
Cancer Res; 1987 Aug; 47(15):4184-8. PubMed ID: 3038309
[TBL] [Abstract][Full Text] [Related]
17. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.
Tsuji-Kawahara S; Chikaishi T; Takeda E; Kato M; Kinoshita S; Kajiwara E; Takamura S; Miyazawa M
J Virol; 2010 Jun; 84(12):6082-95. PubMed ID: 20375169
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous regression of Friend-virus-induced erythroleukemia. VII. The genetic control of regression.
Dietz M; Fouchey S; Furmanski P
Int J Cancer; 1981 Mar; 27(3):341-8. PubMed ID: 6945295
[TBL] [Abstract][Full Text] [Related]
19. Expression of virus-associated antigens and immune cell functions during spontaneous regression of the Friend viral murine leukemia.
Cerny J; Essex M; Rich MA; Hardy WD
Int J Cancer; 1975 Feb; 15(2):351-65. PubMed ID: 47847
[TBL] [Abstract][Full Text] [Related]
20. Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex.
Chesebro B; Wehrly K
Proc Natl Acad Sci U S A; 1979 Jan; 76(1):425-9. PubMed ID: 284359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
